Focus on RAS codon 61 mutations in metastatic colorectal cancer (mCRC): A retrospective analysis

被引：0

作者：

Schietroma, F. ^{[1
]}

Anghelone, A. ^{[2
]}

Valente, G. ^{[1
]}

Beccia, V. ^{[1
]}

Caira, G. ^{[1
]}

Spring, A. ^{[1
]}

Trovato, G. ^{[1
]}

Di Bello, A. ^{[1
]}

Ceccarelli, A. ^{[1
]}

Chiofalo, L. ^{[1
]}

Perazzo, S. ^{[1
]}

Bensi, M. ^{[1
]}

Basso, M. ^{[1
]}

Pozzo, C. ^{[1
]}

Salvatore, L. ^{[1
]}

Calegari, M. ^{[1
]}

Tortora, G. ^{[1
]}

机构：

[1] Univ Cattol Sacro Cuore, Ctr Comprehens Canc, Fondazione Policlinico Univ Agostino Gemelli, Oncol Med, Rome, Italy

[2] Campus Bio Medico Rome Univ, Dept Med Oncol, Rome, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.209

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-153

引用

页码：S69 / S69

页数：1

共 50 条

[21] Polymorphism detection of K-Ras mutations using high-resolution melting analysis in Mexican patients with metastatic colorectal cancer (mCRC)
Astudillo, H.
Sanchez-Guillen, J.
Romero-Garcia, P.
Bastarrachea-Ortiz, J.
Morgan-Villela, G.
Salazar, J. M.
Vazquez-Rivera, V. M.
Ruiz-Calzada, H.
Cortes-Esteban, P.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[22] ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer
Guillaume Passot
Jean-Nicolas Vauthey
Yun Shin Chun
Annals of Surgical Oncology, 2018, 25 : 850 - 851
[23] Characteristics and treatment effect of senior patients with metastatic colorectal cancer (mCRC): A retrospective analysis.
Boudreault, J.
Tehfe, M. A.
Aubin, F.
Sylvestre, M.
Ayoub, J. M.
Richard, C. S.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[24] A multicenter, multinational retrospective analysis of mitomycin C (MMC) in refractory metastatic colorectal cancer (mCRC)
Ferrarotto, R.
Machado, K. K.
Mak, M. P.
Vieira, V. A.
Takahashi, T. K.
Saragiotto, D. F.
Kopetz, S.
Overman, M. J.
Hoff, P. M.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[25] ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer
Passot, Guillaume
Vauthey, Jean-Nicolas
Chun, Yun Shin
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 850 - 851
[26] Timing of testing for K-ras mutational status in metastatic colorectal cancer (mCRC).
Corral, Mitra
Sotak, Michelle
Chastek, Benjamin
Penrod, John R.
Cairns, Jessica
Williams, David A.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[27] Impact of RAS testing on treatment duration among patients with metastatic colorectal cancer (mCRC).
Bach, Bruce A.
Christodoulopoulou, Alexandra
Klink, Andrew
Hechmati, Guy
Mujumdar, Urvi
Feinberg, Bruce A.
Fakih, Marwan
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[28] Minor RAS mutations as predictors of survival in recurrent or metastatic colorectal cancer: A retrospective study in a single institution
Kojitani, Y.
Sakai, D.
Amano, Y.
Ogata, T.
Kitakaze, M.
Sueda, T.
Otsuka, T.
Nishio, M.
Ishihara, M.
Nishimura, J.
Sugimoto, N.
Yagi, T.
Yasui, M.
Kudo, T.
ANNALS OF ONCOLOGY, 2024, 35 : S45 - S45
[29] RAS Registry: Molecular pathological analysis of RAS mutations in mCRC
Schirmacher, P.
Tannapfel, A.
Dietel, M.
Roecken, C.
Buettner, R.
Chen, Y.
Aigner, T.
Haas, C.
Knolle, J.
Kellner, U.
Streckert, H. -J.
Reineke-Plaass, T.
Meier, T.
Sterlacci, W.
Bittmann, I.
Streubel, A.
Schildgen, V.
Steinbach-Buechert, A. -K.
Krenzer, S.
Baretton, G. B.
VIRCHOWS ARCHIV, 2017, 471 : S33 - S34
[30] Retrospective RAS analysis of the EPIC trial: Cetuximab plus irinotecan vs irinotecan in patients (pts) with second-line metastatic colorectal cancer (mCRC)
Sobrero, A.
Lenz, H-J.
Eng, C.
Scheithauer, W.
Middleton, G.
Chen, W.
Esser, R.
Nippgen, J.
Burris, H.
ANNALS OF ONCOLOGY, 2018, 29 : 163 - 163

← 1 2 3 4 5 →